Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data

The Lancet - Tập 391 Số 10124 - Trang 939-948 - 2018
Stuart J. Head1, Milan Milojevic1, Joost Daemen2, Jung‐Min Ahn3, Eric Boersma2, Evald Høj Christiansen4, Michaël Domanski5,6, Michael E. Farkouh5,6, Marcus Flather7, Valentín Fuster5, Mark A. Hlatky8, Niels Ramsing Holm4, Whady Hueb9, Masoor Kamalesh10, Young‐Hak Kim3, Timo H. Mäkikallio11, Friedrich W. Mohr12, Grigorios Papageorgiou13,1, Seung‐Jung Park3, Alfredo E. Rodríguez14, Joseph F. Sabik15, Rod Stables16, Gregg W. Stone17, Patrick W. Serruys18, A. Pieter Kappetein1
1Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands
2Department of Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands
3Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
4Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
5Icahn School of Medicine at Mount Sinai, New York, NY, USA.
6Peter Munk Cardiac Centre and The Heart and Stroke Richard Lewar Centre, University of Toronto, Toronto, ON, Canada
7Norwich Medical School, University of East Anglia and Norfolk and Norwich University Hospital, Norwich, UK
8Stanford University School of Medicine, Stanford, CA, USA
9Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil
10Richard L. Roudebush VA Medical Center, Indianapolis, IN USA
11Department of Cardiology, Oulu University Hospital, Oulu, Finland
12Department of Cardiac Surgery, Herzzentrum, Universität Leipzig, Leipzig, Germany
13Department of Biostatistics, Erasmus University Medical Center Rotterdam, Netherlands
14Cardiac Unit, Otamendi Hospital, Buenos Aires, Argentina
15Department Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
16Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Liverpool, UK
17Columbia University Medical Center and the Center for Clinical Trials, Cardiovascular Research Foundation, New York, NY, USA
18Imperial College London, London, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hlatky, 2009, Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials, Lancet, 373, 1190, 10.1016/S0140-6736(09)60552-3

Daemen, 2008, Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials, Circulation, 118, 1146, 10.1161/CIRCULATIONAHA.107.752147

Stefanini, 2013, Drug-eluting coronary-artery stents, N Engl J Med, 368, 254, 10.1056/NEJMra1210816

Serruys, 2009, Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease, N Engl J Med, 360, 961, 10.1056/NEJMoa0804626

Park, 2011, Randomized trial of stents versus bypass surgery for left main coronary artery disease, N Engl J Med, 364, 1718, 10.1056/NEJMoa1100452

Farkouh, 2012, Strategies for multivessel revascularization in patients with diabetes, N Engl J Med, 367, 2375, 10.1056/NEJMoa1211585

Kamalesh, 2013, Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes, J Am Coll Cardiol, 61, 808, 10.1016/j.jacc.2012.11.044

Park, 2015, Trial of everolimus-eluting stents or bypass surgery for coronary disease, N Engl J Med, 372, 1204, 10.1056/NEJMoa1415447

Makikallio, 2016, Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial, Lancet, 388, 2743, 10.1016/S0140-6736(16)32052-9

Stone, 2016, Everolimus-eluting stents or bypass surgery for left main coronary artery disease, N Engl J Med, 375, 2223, 10.1056/NEJMoa1610227

Higgins, 2011, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, 343, d5928, 10.1136/bmj.d5928

Sianos, 2005, The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease, EuroIntervention, 1, 219

Stewart, 2015, Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD statement, JAMA, 313, 1657, 10.1001/jama.2015.3656

Buszman, 2016, Left main stenting in comparison with surgical revascularization: 10-year outcomes of the (Left Main Coronary Artery Stenting) LE MANS trial, JACC Cardiovasc Interv, 9, 318, 10.1016/j.jcin.2015.10.044

Rodriguez, 2001, Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators, J Am Coll Cardiol, 37, 51, 10.1016/S0735-1097(00)01052-4

Serruys, 2001, Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease, N Engl J Med, 344, 1117, 10.1056/NEJM200104123441502

Hueb, 2004, The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results, J Am Coll Cardiol, 43, 1743, 10.1016/j.jacc.2003.08.065

2002, Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial, Lancet, 360, 965, 10.1016/S0140-6736(02)11078-6

Head, 2012, Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries, JACC Cardiovasc Interv, 5, 618, 10.1016/j.jcin.2012.02.013

Head, 2013, The rationale for heart team decision-making for patients with stable, complex coronary artery disease, Eur Heart J, 34, 2510, 10.1093/eurheartj/eht059

Farooq, 2013, Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II, Lancet, 381, 639, 10.1016/S0140-6736(13)60108-7

Mohr, 2013, Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial, Lancet, 381, 629, 10.1016/S0140-6736(13)60141-5

Head, 2014, Coronary artery bypass grafting vs percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial, Eur Heart J, 35, 2821, 10.1093/eurheartj/ehu213

Bangalore, 2015, Everolimus-eluting stents or bypass surgery for multivessel coronary disease, N Engl J Med, 372, 1213, 10.1056/NEJMoa1412168

Weintraub, 2012, Comparative effectiveness of revascularization strategies, N Engl J Med, 366, 1467, 10.1056/NEJMoa1110717

Morice, 2014, Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial, Circulation, 129, 2388, 10.1161/CIRCULATIONAHA.113.006689

Christiansen, 2017, Everolimus-eluting stents or bypass surgery for left main coronary disease, N Engl J Med, 376, 1088

Thông tin
Thông tin xuất bản

The Lancet

Tập 391 Số 10124

939-948

Thông tin tác giả